secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001493152-24-042455
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience makes corporate presentation available to investors
-------------------------------------------------------------------

- Company filed a corporate presentation dated October 25, 2024 as Exhibit 99.1.
- Presentation will be used in meetings with investors and analysts starting October 25, 2024.
- Copy available on company's investor relations website under Presentations section.
- No specific financial or pipeline updates disclosed in the filing; presentation content not provided.
- Filing is routine Regulation FD disclosure; no material new information can be confirmed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224042455/0001493152-24-042455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315224042455/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer